Pharma group estimates Camizestrant could be worth up to $5bn of sales in its peak year
A London-based start-up employs bioprospectors to scour the world for DNA to feed AI models building a digital tree of life
We must recognise and protect the pipelines that lead from research to real-world benefit
If successful, it would be the first new class of drug against certain bacteria strains for more than 50 years
The Enhanced Games spotlight a growing interest in drugs not only to improve performance, but also to treat depression
The technology exists to identify new threats from infected animals, laboratory accidents or rogue states — let’s use it
Discovery shows how climate change is driving spread of tropical diseases to new regions
Two new studies could help develop better therapies for rejuvenation and regeneration
WHO agreement aims to close resource gaps that undermined Covid response
Child suffering from rare liver disease shows improved health after treatment
Danish company has had some poor results for new drugs designed to replace treatments when they go off patent
Doctors and pharmacists are using DNA information to tailor treatments
Universities and medical centres have already had to cut costs as the US government slashed spending on a range of programmes
Europe’s swine herds could become a ‘dangerous virus laboratory’, Bernhard Url says
A warming world accelerates rise of infection-causing species in echo of television series ‘The Last of Us’
Johnson & Johnson-backed HistoSonics seeks valuation of more than $2.5bn
Virologists from 40 countries say year-long US outbreak raises risk that virus will spread between humans
The FT’s sixth annual ranking by revenue growth. Plus: how healthcare, technology and energy are boosting sales and a deep dive into the Mexican fintech, Canadian oil and the renewables sectors
Bowel cancer is projected to become the biggest cause of cancer deaths among young adults by 2030
Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades
Delays to treatment of common women’s health condition criticised by doctors and sufferers
Novartis and Sanofi CEOs push for European benchmark against US prices
Californian researchers and groups such as Precision Neuroscience use implants and AI to make advances in ‘voice prosthesis’
Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%
Move comes as government seeks to boost UK’s standing as drugs research leader
